Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Add To Watchlist

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Reply from Robert Farrell Jan 5th

View:

Post by TheQQMon on Jan 09, 2021 10:51am

Reply from Robert Farrell Jan 5th

Got a reply

190

Comment

Comment by TheQQMon on Jan 09, 2021 10:52am

Hello [TheQQMon], On Thursday last week, we received another set of comments and questions from the BCSC, which we have responded to. The BCSC is also requiring that we issue a press release that will include a fulsome discussion of the risks inherent with developing R-107 for Covid-19, such as the need to raise funds for clinical studies ...more

231

Comment

Comment by Chritters on Jan 09, 2021 11:08am

Thank you for posting this, Seems Stockhouse is the only place we can get the truth, Between Kalyterian and The Facebook Kaly Group making stuff up for the last 6.5 Months of this Halt, Nice to see someone post something Legit.

235

Comment